Título:	Chromatographic method for determining 6‑mercaptopurine in skin permeation assays for assessing cutaneous exposure risk
Autor(es):	Oliveira, Gabriel de Sousa Lima, Ana Luiza Gross, Idejan P. Barreto, Livia Sá Souza, Patrícia Medeiros Gratieri, Tais Gelfuso, Guilherme Martins Cunha Filho, Marcílio Sérgio Soares da
ORCID:	https://orcid.org/0000-0001-6481-2364 https://orcid.org/0009-0005-7175-164X https://orcid.org/0000-0002-9167-6852
Afiliação do autor:	University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Faculty of Ceilandia University of Brasilia, School of Health Sciences University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC)
Assunto:	Absorção Medicamentos Cromatografia a líquido de alta eficiência Profissionais da saúde Riscos ocupacionais
Data de publicação:	16-jul-2025
Editora:	American Chemical Society
Referência:	OLIVEIRA, Gabriel de S. et al. Chromatographic method for determining 6‑mercaptopurine in skin permeation assays for assessing cutaneous exposure risk. ACS Omega, [S. l.], v. 10, n. 29, 32384-32390. DOI: https://doi.org/10.1021/acsomega.5c04686. Disponível em: https://pubs.acs.org/doi/10.1021/acsomega.5c04686. Acesso em: 10 dez. 2025.
Abstract:	6-Mercaptopurine monohydrate (6-MP) is a drug often used in leukemia chemotherapy, but limited information is available about its cutaneous absorption, which raises concerns about occupational risks for healthcare professionals and caregivers. This study aimed to validate an analytical method using high-performance liquid chromatography (HPLC) for quantifying 6-MP in the skin, allowing the assessment of its cutaneous permeation. The validation of the proposed method demonstrated high selectivity against skin interferents, linearity (R = 0.999), precision, and sensitivity, with detection and quantification limits of 0.13 μg/mL and 0.39 μg/mL, respectively. The developed extraction procedure allowed reproducible drug recovery from the stratum corneum and remaining skin, minimizing the impact of enzymatic metabolism in these biological matrices. Using the developed method, a preliminary skin permeation test on porcine skin showed that 6-MP is retained mainly in the remaining skin, accumulating approximately 2% of the total dose applied within 30 min of testing, suggesting a high risk of dermal exposure. The results reinforce the need for preventive measures, such as personal protective equipment and strict handling protocols, to minimize drug exposure. Thus, the method described constitutes an essential tool in assessing the risk of topical contamination of 6-MP and can be used in long-term studies of skin permeation of this drug, contributing to the safety of health professionals, caregivers, and patients.
Unidade Acadêmica:	Faculdade de Ciências da Saúde (FS) Departamento de Farmácia (FS FAR) Faculdade de Ciências e Tecnologias em Saúde (FCTS) – Campus UnB Ceilândia
Programa de pós-graduação:	Programa de Pós-Graduação em Ciências da Saúde
Licença:	This article is licensed under CC-BY 4.0
DOI:	https://doi.org/10.1021/acsomega.5c04686
Aparece nas coleções:	Artigos publicados em periódicos e afins

Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.